'ABIC International on Biomedical Research Translation 2024' pioneers the future of biomedical innovations by translating discoveries into tangible healthcare improvements
The one-day program aims to further ABIC’s ongoing efforts in establishing international connections through the assembly of distinguished minds. The exchange of ideas and expertise propels advancements in biomedical research, and translates discoveries into tangible improvements in healthcare. By working together across borders and disciplines, the event reinforced the necessity of tackling pressing challenges and creating lasting impacts on the biomedical fields.
Prof. Anderson Shum, Centre Director of ABIC, commenced the symposium with welcome remarks, expressing his ambitions for the prestigious gathering. Dr. Sunny Chai, SBS, BBS, JP, Chairman of Hong Kong Science and Technology Parks Corporation, affirmed ABIC’s endeavors with robust national support and a dynamic local ecosystem in his opening remarks. Prof. Sun Dong, JP, Secretary for Innovation, Technology and Industry of the Hong Kong SAR Government, shared his vision about the I&T development of Hong Kong in the keynote.
Prof. Sun Dong, JP, Secretary for Innovation, Technology and Industry of the Hong Kong SAR Government, was the keynote speaker.
In his remarks, Prof. Sun highlighted that promoting innovation and technology (I&T) has been running high:
“It is exciting news that Hong Kong once again has 5 universities in the world’s top 70, as announced by the QS World University Rankings a few days ago. 3 of them, are ranked in the top 50; and HKU the top 17th. Hong Kong’s strong R&D capability and world-class researchers are being recognized globally. As one of the most international cities in the world, Hong Kong has been playing a vital role in fostering the local I&T collaboration.”
Prof. Anderson Shum, Centre Director of ABIC, commenced the symposium with welcome remarks, expressing his ambitions of bringing together such a prestigious gathering:
“Together, let’s continue our collaborative efforts to network with the world’s talented scientists, industry partners, universities, institutions, and governments to tackle the challenges in the biomedical area and drive sustainable technology innovation.
I hope this forum will foster new partnerships and inspire continued innovations to create a brighter future for the world.”
Dr. Sunny Ngai-chiu Chai, SBS, BBS, JP, Chairman of Hong Kong Science and Technology Parks Corporation, affirmed ABIC’s endeavors with robust national support and a dynamic local ecosystem in his opening remarks:
“ABIC is under InnoHK who has emerged as a leader in health technology, showcasing the potential power of collaborative innovation in health care and setting a scene for the industry’s future.”
The event attracted a remarkable lineup of domain experts from renowned universities and research institutions around the globe, fostering scholarly dialogue on the translation of biomedical innovations. Notable speakers are briefly listed as follows:
• Prof. Andreas Bausch (TUM)
• Prof. Barbara Chan (CUHK)
• Prof. Rong Fan (Yale)
• Prof. Daniel Fletcher (UCB)
• Prof. Wei Gao (Caltech)
• Prof. Tuomas Knowles (Cambridge)
• Prof. Jia Liu (Harvard SEAS)
• Prof. Lingyan Shi (UCSD)
• Prof. Anderson Shum (HKU)
• Prof. David Weitz (Harvard SEAS)
• Prof. Denis Wirtz (Johns Hopkins)
• Prof. Kenneth Wong (HKU)
• Prof. Bing Xu (Brandeis)
• Prof. Shrike Zhang (Harvard Med)
• Prof. Yongguan Zhu (UCAS)
Furthermore, the event scheduled sound bites sessions contributed by next-generation researchers and entrepreneurs, offering them a valuable platform to circulate their innovative projects, share their experiences on science research and commercialization, and engage with the broader biomedical community. In addition to the speeches, the Centre has also showcased their award-winning innovations from the Geneva International Exhibition of Inventions 2024.
The symposium also featured the signing of Memoranda of Understanding (MOU) with three esteemed partners – Bioworld Ventures, China Prosperity Capital and Gaw Capital – signifying ABIC’s commitment to research translation.